Pasar al contenido principal

NUEVOS NANOSISTEMAS ACTIVADORES DE LA AST PARA EL TRATAMIENTO DE LA ISQUEMIA CEREBRAL

SAF2017-87670-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario ASOCIACIÓN CENTRO DE INVESTIGACION COOP. BIOMATERIALES

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

MRI study of the influence of surface coating aging on the in vivo biodistribution of iron oxide nanoparticles

  • Carregal-Romero, Susana
  • Plaza-García, Sandra
  • Piñol, Rafael
  • Murillo, José Luis
  • Ruiz-Cabello, Jesús
  • Padro, Daniel
  • Millán, Ángel
  • Ramos-Cabrer, Pedro
This article belongs to the Special Issue Functional Nanomaterials for Biosensing and Bioimaging., Medical imaging is an active field of research that fosters the necessity for novel multimodal imaging probes. In this line, nanoparticle-based contrast agents are of special interest, since those can host functional entities either within their interior, reducing potential toxic effects of the imaging tracers, or on their surface, providing high payloads of probes, due to their large surface-to-volume ratio. The long-term stability of the particles in solution is an aspect usually under-tackled during probe design in research laboratories, since their performance is generally tested briefly after synthesis. This may jeopardize a later translation into practical medical devices, due to stability reasons. To dig into the effects of nanoparticle aging in solution, with respect to their behavior in vivo, iron oxide stealth nanoparticles were used at two stages (3 weeks vs. 9 months in solution), analyzing their biodistribution in mice. Both sets of nanoprobes showed similar sizes, zeta potentials, and morphology, as observed by dynamic light scattering (DLS) and transmission electronic microscopy (TEM), but fresh nanoparticles accumulated in the kidneys after systemic administration, while aged ones accumulated in liver and spleen, confirming an enormous effect of particle aging on their in vivo behavior, despite barely noticeable changes perceived on a simple inspection of their structural integrity., This research was funded by Ministerio de Ciencia, Innovación y Universidades (MEIC) (grant number SAF2017-87670-R and SAF2017-84494-C2-R), Programa Red Guipuzcoana de Ciencia, Tecnología e Información (Grant number 2018-CIEN-000058-01), and The EU (FET-OPEN NanoTBTech grant Number 801305). J.R.-C. and P.R.-C. are funded by Ikerbasque, The Basque foundation for science., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

PLGA protein nanocarriers with tailor-made fluorescence/MRI/PET imaging modalities

  • Zhang, Yajie
  • García Gabilondo, Miguel
  • Grayston, Alba
  • Feiner, Irene V. J.
  • Anton Sales, Irene
  • Azevedo Loiola, Rodrigo
  • Llop, Jordi
  • Ramos Cabrer, Pedro
  • Barba, Ignasi
  • Garcia Dorado, David
  • Gosselet, Fabien
  • Rosell, Anna
  • Roig Serra, Anna
Designing theranostic nanocarriers with high protein payload and multimodality tracking without cross interferences between the different imaging probes and the delicate protein cargo is challenging. Here, chemical modifications of poly(lactic-co-glycolic acid) (PLGA) to produce nanocapsules (NCs) that incorporate several imaging moieties are reported. The biocompatible and biodegradable PLGA-NCs can be endowed with a magnetic resonance imaging (MRI) reporter, two fluorescence imaging probes (blue/NIR) and a positron emission tomography (PET) reporter. The modular integration of these imaging moieties into the shell of the NCs is successfully achieved without affecting the morphochemical properties of the nanocarrier or the protein loading capacity. In vivo biodistribution of the NCs is monitored by MRI, PET and NIRF and the results from different techniques are analyzed comparatively. The viabilities of two different human endothelial cells in vitro show no toxicity for NC concentration up to 100 μg mL−1 . The morbidity of mice for 2 weeks after systemic administration and the hepatic/pancreatic enzymes at the plasma level indicate their in vivo biosafety. In summary, the new theranostic PLGA nanoplatform presented here shows versatile in vitro/in vivo multimodal imaging capabilities, excellent biosafety and over 1 wt% protein loading., The Acciones Complementarias program from the Instituto de Salud Carlos III, Spain, co-financed by the European Regional Development Fund (AC17/00004 grant) as part of the MAGBBRIS project (Euronanomed III 8th joint call), and the RETICS INVICTUS RD16/0019/0021 are acknowledged. The Miguel Servet program (CPII15/00003) and PFIS program (FI17/00073) from Fondo de Investigaciones SanitariasInstituto de Salud Carlos III and ERDF supported A. Rosell and A. G. research contracts. This work was also partially supported by the Spanish Ministry of Science, Innovation and Universities through the grants PCIN-2017-090, RTI2018- 096273-B-I00, CTQ2017-87637-R, SAF2017-87670-R, SEV-2015- 0496 and MDM-2017-0720 and by the Generalitat de Catalunya grants (2017SGR765 & 2017SGR1427). Yajie Zhang is supported by the China Scholarship Council (CSC). FG and RAL are supported by the French national agency (ANR) through the grant ANR-17-ENM3-0005-01. The authors thank Dr Vanessa GómezVallejo, Dr Unai Cossío, Dr Xabier Rios and Zuriñe Baz for support in labelling and PET in vivo experimentation. We acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

MRI/Photoluminescence Dual-Modal Imaging Magnetic PLGA Nanocapsules for Theranostics

  • Zhang, Yajie
  • García Gabilondo, Miguel
  • Rosell, Anna
  • Roig Serra, Anna
Developing multifunctional and biocompatible drug delivery nanoplatforms that integrate high drug loads and multiple imaging modalities avoiding cross-interferences is extremely challenging. Here we report on the successful chemical reaction of the high quantum yield biodegradable and photoluminescent polyester (BPLP) with the poly(lactic-co-glycolic acid) (PLGA) polymer to fabricate biocompatible photoluminescent nanocapsules (NCs). Furthermore, we transform the PLGA-BPLP NCs into a magnetic resonance (MR)/photoluminescence dual-modal imaging theranostic platform by incorporating superparamagnetic iron oxide nanoparticles (SPIONs) into the polymeric shell. In vitro phantoms confirmed the excellent MRI-r2 relaxivity values of the NCs whilst the cellular uptake of these NCs was clearly observed by fluorescence optical imaging. Besides, the NCs (mean size ~270 nm) were loaded with ~1 wt% of a model protein (BSA) and their PEGylation provided a more hydrophilic surface. The NCs show biocompatibility in vitro, as hCMEC/D3 endothelial cells viability was not affected for particle concentration up to 500 μg/mL. Interestingly, NCs decorated with SPIONs can be exploited for magnetic guiding and retention., This work was partially supported by the Spanish Ministry of Science, Innovation and Universities through the grants PCIN-2017-090, RTI2018-096273-B-I00, CTQ2017-87637-R, SAF2017-87670-R, SEV-2015-0496 and MDM-2017-0720 and by the Generalitat de Catalunya grants (2017SGR765 & 2017SGR1427). Yajie Zhang was supported by the China Scholarship Council (CSC). The Acciones Complementarias program from the Instituto de Salud Carlos III, Spain, co-financed by the European Regional Development Fund (AC17/00004 grant) as part of the MAGBBRIS project (Euronanomed III 8th joint call), and the RETICS INVICTUS RD16/0019/0021 were acknowledged. Miguel Servet program (CPII15/00003) from Fondo de Investigaciones Sanitarias-Instituto de Salud Carlos III and ERDF, supported A. Roig research contract., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Magnetic core-shell nanowires as MRI contrast agents for cell tracking

  • Martínez-Banderas, Aldo Isaac
  • Aires, Antonio
  • Plaza-García, Sandra
  • Colás, Lorena
  • Moreno, Julián A.
  • Ravasi, Timothy
  • Merzaban, Jasmeen S.
  • Ramos-Cabrer, Pedro
  • Cortajarena, Aitziber L.
  • Kosel, Jürgen
© The Author(s) 2020., [Background]: Identifying the precise location of cells and their migration dynamics is of utmost importance for achieving the therapeutic potential of cells after implantation into a host. Magnetic resonance imaging is a suitable, non-invasive technique for cell monitoring when used in combination with contrast agents., [Results]: This work shows that nanowires with an iron core and an iron oxide shell are excellent materials for this application, due to their customizable magnetic properties and biocompatibility. The longitudinal and transverse magnetic relaxivities of the core–shell nanowires were evaluated at 1.5 T, revealing a high performance as T2 contrast agents. Different levels of oxidation and various surface coatings were tested at 7 T. Their effects on the T2 contrast were reflected in the tailored transverse relaxivities. Finally, the detection of nanowire-labeled breast cancer cells was demonstrated in T2-weighted images of cells implanted in both, in vitro in tissue-mimicking phantoms and in vivo in mouse brain. Labeling the cells with a nanowire concentration of 0.8 μg of Fe/mL allowed the detection of 25 cells/µL in vitro, diminishing the possibility of side effects. This performance enabled an efficient labelling for high-resolution cell detection after in vivo implantation (~ 10 nanowire-labeled cells) over a minimum of 40 days., [Conclusions]: Iron-iron oxide core–shell nanowires enabled the efficient and longitudinal cellular detection through magnetic resonance imaging acting as T2 contrast agents. Combined with the possibility of magnetic guidance as well as triggering of cellular responses, for instance by the recently discovered strong photothermal response, opens the door to new horizons in cell therapy and make iron-iron oxide core–shell nanowires a promising theranostic platform., Research reported in this publication was supported by the King Abdullah University of Science and Technology (KAUST), The Spanish State Research Agency (RETOS Program Grant No. BIO2016-77367-R and SAF2017-87670-R, Maria de Maeztu Units of Excellence Program Grant No. MDM-2017-0720), and the Basque Government (Elkartek KK-2017/00008).
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

MRI Study of the Influence of Surface Coating Aging on the In Vivo Biodistribution of Iron Oxide Nanoparticles

  • Carregal-Romero, S.
  • Plaza-García, S.
  • Piñol, R.
  • Murillo, J.L.
  • Ruiz-Cabello, J.
  • Padro, D.
  • Millán, A.
  • Ramos-Cabrer, P.
Medical imaging is an active field of research that fosters the necessity for novel multimodal imaging probes. In this line, nanoparticle-based contrast agents are of special interest, since those can host functional entities either within their interior, reducing potential toxic effects of the imaging tracers, or on their surface, providing high payloads of probes, due to their large surface-to-volume ratio. The long-term stability of the particles in solution is an aspect usually under-tackled during probe design in research laboratories, since their performance is generally tested briefly after synthesis. This may jeopardize a later translation into practical medical devices, due to stability reasons. To dig into the effects of nanoparticle aging in solution, with respect to their behavior in vivo, iron oxide stealth nanoparticles were used at two stages (3 weeks vs. 9 months in solution), analyzing their biodistribution in mice. Both sets of nanoprobes showed similar sizes, zeta potentials, and morphology, as observed by dynamic light scattering (DLS) and transmission electronic microscopy (TEM), but fresh nanoparticles accumulated in the kidneys after systemic administration, while aged ones accumulated in liver and spleen, confirming an enormous effect of particle aging on their in vivo behavior, despite barely noticeable changes perceived on a simple inspection of their structural integrity.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

MRI/Photoluminescence Dual-Modal Imaging Magnetic PLGA Nanocapsules for Theranostics

  • Zhang, Yajie|||0000-0003-1566-1007
  • García-Gabilondo, Miguel|||0000-0002-2015-2621
  • Rosell Novel, Anna|||0000-0003-1082-3599
  • Roig i Serra, Anna|||0000-0001-6464-7573
Developing multifunctional and biocompatible drug delivery nanoplatforms that integrate high drug loads and multiple imaging modalities avoiding cross-interferences is extremely challenging. Here we report on the successful chemical reaction of the high quantum yield biodegradable and photoluminescent polyester (BPLP) with the poly(lactic-co-glycolic acid) (PLGA) polymer to fabricate biocompatible photoluminescent nanocapsules (NCs). Furthermore, we transform the PLGA-BPLP NCs into a magnetic resonance (MR)/photoluminescence dual-modal imaging theranostic platform by incorporating superparamagnetic iron oxide nanoparticles (SPIONs) into the polymeric shell. In vitro phantoms confirmed the excellent MRI-r relaxivity values of the NCs whilst the cellular uptake of these NCs was clearly observed by fluorescence optical imaging. Besides, the NCs (mean size ~270 nm) were loaded with ~1 wt% of a model protein (BSA) and their PEGylation provided a more hydrophilic surface. The NCs show biocompatibility in vitro, as hCMEC/D3 endothelial cells viability was not affected for particle concentration up to 500 μg/mL. Interestingly, NCs decorated with SPIONs can be exploited for magnetic guiding and retention.